OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid · OpenFeds · OpenSpending

© 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodology•Download Data
  1. Home
  2. Procedures
  3. J9144
  4. Cost Analysis

How Much Does Injection, daratumumab, 10 mg and hyaluronidase-fihj Cost on Medicare?

Cost analysis for CPT J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj

Share:

Average Medicare Payment

N/A

Total Payments (Latest)

N/A

Services (Latest)

N/A

Price Change (–)

N/A

🗺️ State-by-State Cost Variation

The most expensive state pays 1.1x more than the cheapest for this procedure. KS averages $38.62 vs SC at $36.56.

StateAvg PaymentTotal PaymentsServicesProviders
KS$38.62$2.1M53.3K8
SD$38.34$213.9K5.6K1
CT$38.24$302.8K7.9K1
MA$38.05$424.6K11.2K1
NC$38.02$2.7M70.6K12
OK$37.99$1.5M39.2K6
ME$37.98$1.6M42.8K2
OR$37.97$1.4M36.2K4
MI$37.97$553.6K14.6K2
CO$37.94$8.5M224.5K24
AL$37.93$1.8M46.8K4
NY$37.91$11.5M303.0K23
TX$37.90$6.8M180.7K28
NE$37.89$4.8M126.2K11
DE$37.88$2.9M77.8K7
ID$37.88$490.9K13.0K1
KY$37.86$463.4K12.2K1
MO$37.86$7.1M187.4K23
WI$37.85$2.0M52.0K5
NJ$37.85$3.8M101.5K8
VT$37.83$565.1K14.9K1
PA$37.79$6.9M183.6K22
CA$37.78$22.1M585.0K35
IL$37.74$16.1M425.7K47
VA$37.72$18.3M485.1K55
GA$37.70$1.9M51.1K6
AZ$37.70$14.7M389.9K42
FL$37.66$30.8M817.6K75
MN$37.64$7.7M204.4K47
MS$37.63$2.5M67.1K4
TN$37.57$9.8M260.6K21
MD$37.52$13.8M368.3K28
IA$37.51$3.8M101.7K8
AR$37.47$4.3M115.9K12
IN$37.37$968.5K25.9K2
AK$37.22$817.3K22.0K2
OH$37.08$1.5M41.0K4
WA$36.75$3.6M97.4K10
NV$36.58$4.9M133.9K11
SC$36.56$3.8M105.1K11

💰 Who Bills the Most for This Procedure?

ProviderSpecialtyStatePaymentsServicesAvg/Service
Robert VescioHematology-OncologyCA$1.9M50.4K$37.92
Ruben NiesvizkyMedical OncologyNY$1.8M48.4K$37.91
Roger PearseMedical OncologyNY$1.4M37.7K$37.97
Amy McmullenMedical OncologyCA$1.4M37.3K$37.80
Jorge Monge UrreaMedical OncologyCO$1.4M36.0K$37.96
Jamal MislehHematology-OncologyDE$1.3M34.4K$37.92
Mary MulcahyMedical OncologyIL$1.3M34.0K$38.09
Hakan KayaMedical OncologyWA$1.3M35.6K$36.28
Sarah LarsonHematology-OncologyCA$1.2M33.1K$37.53
David SmithHematology-OncologyMD$1.2M32.6K$37.81
Daniel GreenwaldMedical OncologyCA$1.2M32.2K$38.03
Stefano TarantoloMedical OncologyNE$1.2M31.5K$37.84
Thomas BurokerMedical OncologyIA$1.2M31.1K$37.90
Luis ChuHematology-OncologyFL$1.2M30.8K$37.66
Brian DicarloMedical OncologyCA$1.1M30.2K$37.91
Amrita KrishnanHematology-OncologyCA$1.1M29.9K$37.84
Anuj MahindraHematology-OncologyCA$1.1M29.3K$37.99
Andrew LipmanHematology-OncologyFL$1.1M29.2K$37.98
Thomas BlomHematology-OncologyNJ$1.1M29.5K$37.45
Ross KernsHematology-OncologyTN$1.1M29.3K$37.60

🤔 Is Injection, daratumumab, 10 mg and hyaluronidase-fihj Overpriced?

Based on the data, CPT J9144 shows a 1.1x variation in pricing across states — relatively consistent by Medicare standards.

Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.

This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.

Data Sources

  • • Centers for Medicare & Medicaid Services (CMS)
  • • Medicare Provider Utilization and Payment Data (2014-2023)
  • • Medicare Physician Fee Schedule

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.